✦ LIBER ✦

Phase I/II trial of oral UFT/Leucovorin (LV) and paclitaxel (P) in the second line treatment of patients (PTS) with metastatic breast cancer (MBC)

✍ Scribed by Klaassen, U.; Lang, S.; Borquez, D.; Oberhoff, C.; Benner, S.; Harstrick, A.; Seeber, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

122 O - A phase I trial of epirubicin (E

✍ R. Salyadori; A. Mlchelotti; E. Baldini; A. Gennari; C. Tibaldi; A. Tognani; P.G 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 167 KB

PP-7-5 phase II study of paclitaxel (P)

✍ Ch. Thomssen; H.-J. Lück; A. du Bois; B. Lisboa; M. Untch; G. Köhler; D. Hecker; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Phase I trial of the oral PARP inhibitor

✍ Dent, Rebecca A; Lindeman, Geoffrey J; Clemons, Mark; Wildiers, Hans; Chan, Arle 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 207 KB

Phase I study of an all-oral combination

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Phase II Multicenter Trial of Albumin-Bo

✍ Lee S. Schwartzberg; Francis P. Arena; David M. Mintzer; Amanda L. Epperson; Mar 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 391 KB

Oral Gossypol in the Treatment of Patien

✍ Catherine Van Poznak; Andrew D. Seidman; Marcus M. Reidenberg; Mark M. Moasser; 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 180 KB